23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
03 juin 2024 08h00 HE
|
23andMe, Inc.
– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate acceptable safety and...
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
30 mai 2024 09h15 HE
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Rhino Health and Medinexo Partner to Expand Data Diversity in Therapeutic Development
22 mai 2024 15h35 HE
|
Rhino Health
Rhino Health and Medinexo are partnering to provide federated access to a global network of hospitals to accelerate biopharma research.
نظير مبادرته الرائدة في مجال غسيل الكلى المنزلي "التخصصي" يفوز بجائزة التأثير التقني من VBHC للعام 2024
16 mai 2024 11h23 HE
|
King Faisal Specialist Hospital & Research Centre
الرياض, May 16, 2024 (GLOBE NEWSWIRE) -- فاز مستشفى الملك فيصل التخصصي ومركز الأبحاث بجائزة التأثير التقني للعام 2024، المقدمة من مركز الرعاية الصحية القائمة على القيمة الأوربي (Value-Based Health...
King Faisal Specialist Hospital & Research Centre Wins 2024 Tech Impact Award from VBHC
16 mai 2024 11h23 HE
|
King Faisal Specialist Hospital & Research Centre
King Faisal Specialist Hospital & Research Centre Wins 2024 Tech Impact Award from VBHC
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
13 mai 2024 09h41 HE
|
King Faisal Specialist Hospital & Research Centre
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value
11 mai 2024 06h01 HE
|
King Faisal Specialist Hospital & Research Centre
KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending ValueDr. Al Fayyadh at Harvard: We Leverage Technology to Tackle Global Health Challenges
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest
09 mai 2024 09h00 HE
|
Curia Global, Inc.
The symposium, Unlocking High-Throughput Biology in Drug Discovery, will take place on May 31 in Seattle and feature industry-leading scientists.
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
09 mai 2024 07h15 HE
|
ADC Therapeutics SA
LAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024...
[Latest] Global Ultrapure Water Market Size/Share Worth USD 3,989 Million by 2033 at a 10.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
02 mai 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Ultrapure Water Market Size, Trends and Insights By Application (Cleaning,...